These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 1270881)

  • 1. Inhibition of platelet aggregation by 5-nitro-2-furaldehyde diacetate with observations on structure-activity relationships.
    Rossi EC; Nimer S; Louis G
    J Lab Clin Med; 1976 Apr; 87(4):703-9. PubMed ID: 1270881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular components of nitrofurantoin critical to its inhibitory effect upon platelet aggregation.
    Rossi EC; Mieyal JJ; Strong JM
    Mol Pharmacol; 1975 Nov; 11(6):751-8. PubMed ID: 1207672
    [No Abstract]   [Full Text] [Related]  

  • 3. Relationship between structure and activity of aspirin-related compounds on the inhibition of in vitro platelet aggregation.
    Dupin JP; Gravier D; Casadebaig F; Boisseau MR; Bernard H
    Farmaco Sci; 1986 Mar; 41(3):205-14. PubMed ID: 3086120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific impairment of ADP-induced platelet aggregation by cannabinoids.
    Nathan I; Dvilansky A; Lazarowitz J; Lander N; Livne A
    Int J Tissue React; 1986; 8(3):193-8. PubMed ID: 3781759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and inhibition of platelet aggregation for some 1-o-chlorophenyl-1,2,3,4-tetrahydroisoquinoline derivatives.
    Yang J; Hua WY; Wang FX; Wang ZY; Wang X
    Bioorg Med Chem; 2004 Dec; 12(24):6547-57. PubMed ID: 15556771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of heparin and heparinoids on platelet aggregation.
    Cepelák V; Roubal Z; Zemanová I; Opatrný K
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):750-60. PubMed ID: 6083950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Potentiating effect of some fatty acids on platelet aggregation induced with ADP, collagen and 1-epinephrine].
    Musso R; Russo M; Raimondo V
    Boll Soc Ital Biol Sper; 1980 Mar; 56(6):569-75. PubMed ID: 7378191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of primary ADP-induced platelet aggregation in normal subjects after administration of nitrofurantoin (furadantin).
    Rossi EC; Levin NW
    J Clin Invest; 1973 Oct; 52(10):2457-67. PubMed ID: 4729043
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of platelet aggregation by moxalactam and free N-methylthiotetrazole.
    Ingalls CS; Somani P; Freimer EH
    Clin Ther; 1989; 11(5):640-51. PubMed ID: 2629724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gallopamil and changes of adenosine diphosphate- and collagen-induced thrombocyte aggregation].
    Költringer P; Langsteger W; Lind P; Pierer G; Reisecker F; Eber O
    Arzneimittelforschung; 1991 Aug; 41(8):786-8. PubMed ID: 1781797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of some antineoplastic drugs (vincristine, doxorubicin and epirubicin) on human platelet aggregation.
    Matera C; Falzarano C; Vacca C; Falciani M; Rossi F
    J Med; 1994; 25(1-2):2-16. PubMed ID: 7930957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro inhibitory activity on human platelet aggregation of novel properly substituted 4-(1-piperazinyl)coumarins.
    Di Braccio M; Grossi G; Roma G; Grazia Signorello M; Leoncini G
    Eur J Med Chem; 2004 May; 39(5):397-409. PubMed ID: 15110966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of proteoglycans (PG) and glycosaminoglycans (GAG) on ADP-, collagen- and thrombin-induced platelet aggregation.
    Klein K; Sinzinger H; Silberbauer K; Stachelberger H; Leithner C
    Artery; 1980; 8(5):410-5. PubMed ID: 6783013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
    Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
    J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: possible involvement of cyclooxygenase blockade and antioxidant activity.
    Fontenele JB; Leal LK; Silveira ER; Felix FH; Bezerra Felipe CF; Viana GS
    J Pharm Pharmacol; 2009 Apr; 61(4):511-5. PubMed ID: 19298699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of cefonicid on platelet aggregation.
    Cazzola M; Santangelo G; Paizis G; Matera C; Rossi F
    Drugs Exp Clin Res; 1991; 17(2):105-8. PubMed ID: 1864223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Some characteristics of mouse platelet aggregation and a comparison of the activity of a range of compounds in mouse and human platelet-rich plasma in vitro.
    Nunn B
    Thromb Haemost; 1981 Feb; 45(1):1-5. PubMed ID: 7245119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide.
    Judge S; Mammen E; Dunbar JC
    J Assoc Acad Minor Phys; 1995; 6(3):100-4. PubMed ID: 7663098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin counteracts the antiaggregating effect of prostacyclin by potentiating platelet aggregation.
    Bertelé V; Roncaglioni MC; Donati MB; de Gaetano G
    Thromb Haemost; 1983 Apr; 49(2):81-3. PubMed ID: 6346573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effect of ethanol on ADP and collagen-induced platelet aggregation.
    Bengmark S; Elmér O; Göransson G; Zoucas E
    Thromb Haemost; 1981 Dec; 46(4):673-5. PubMed ID: 7330816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.